ID

31060

Description

Study of M2ES With Paclitaxel/Carboplatin (TC Regimen) in Advanced Non Small Cell Lung Cancer (NSCLC); ODM derived from: https://clinicaltrials.gov/show/NCT01099124

Link

https://clinicaltrials.gov/show/NCT01099124

Keywords

Versions (1)
  1. 7/16/18 7/16/18 -
Copyright Holder

See clinicaltrials.gov

Uploaded on

July 16, 2018

DOI

To request one please log in.

License

Creative Commons BY 4.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Non Small Cell Lung Cancer NCT01099124

English

Eligibility Non Small Cell Lung Cancer NCT01099124

1 forms  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
1. aged 18-70 years old;
Description

Age

Data type

boolean

Alias
UMLS CUI [1]
C0001779
2. patients with ⅲ/ⅳ nsclc confirmed by histopathology or cytology who ware naive or previous chemotherapy without tc regimen;
Description

Non-Small Cell Lung Carcinoma TNM clinical staging | Therapy naive | Prior Chemotherapy Without TC Regimen

Data type

boolean

Alias
UMLS CUI [1,1]
C0007131
UMLS CUI [1,2]
C3258246
UMLS CUI [2]
C0919936
UMLS CUI [3,1]
C1514457
UMLS CUI [3,2]
C0332288
UMLS CUI [3,3]
C4522122
3. no contraindication for chemotherapy;
Description

Medical contraindication Absent Chemotherapy

Data type

boolean

Alias
UMLS CUI [1,1]
C1301624
UMLS CUI [1,2]
C0332197
UMLS CUI [1,3]
C0392920
4. ecog performance scale 0-2;
Description

ECOG performance status

Data type

boolean

Alias
UMLS CUI [1]
C1520224
5. no history of anti-angiogenesis therapy;
Description

Antiangiogenesis therapy Absent

Data type

boolean

Alias
UMLS CUI [1,1]
C0281318
UMLS CUI [1,2]
C0332197
6. patients are voluntary to participate and sigh the informed contents.
Description

Informed Consent

Data type

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
1. concurrent use of other anti-cancer agents;
Description

Antineoplastic Agents

Data type

boolean

Alias
UMLS CUI [1]
C0003392
2. allergic history to m2es and biological agents;
Description

Hypersensitivity M2ES | Hypersensitivity Biological Factors

Data type

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C2985192
UMLS CUI [2,1]
C0020517
UMLS CUI [2,2]
C0005515
3. pregnant or breast-feeding women;
Description

Pregnancy | Breast Feeding

Data type

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
4. with other malignancy;
Description

Cancer Other

Data type

boolean

Alias
UMLS CUI [1]
C1707251
5. with severe cardiopulmonary disease;
Description

Cor pulmonale Severe

Data type

boolean

Alias
UMLS CUI [1,1]
C0034072
UMLS CUI [1,2]
C0205082
6. uncontrolled brain metastasis patients;
Description

Metastatic malignant neoplasm to brain Uncontrolled

Data type

boolean

Alias
UMLS CUI [1,1]
C0220650
UMLS CUI [1,2]
C0205318
7. other conditions that are regarded for exclusion by the trialists.
Description

Condition Study Subject Participation Status Exclusion

Data type

boolean

Alias
UMLS CUI [1,1]
C0348080
UMLS CUI [1,2]
C2348568
UMLS CUI [1,3]
C2828389
Back to the top of the page

Similar models

Eligibility Non Small Cell Lung Cancer NCT01099124

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Age
Item
1. aged 18-70 years old;
boolean
C0001779 (UMLS CUI [1])
Non-Small Cell Lung Carcinoma TNM clinical staging | Therapy naive | Prior Chemotherapy Without TC Regimen
Item
2. patients with ⅲ/ⅳ nsclc confirmed by histopathology or cytology who ware naive or previous chemotherapy without tc regimen;
boolean
C0007131 (UMLS CUI [1,1])
C3258246 (UMLS CUI [1,2])
C0919936 (UMLS CUI [2])
C1514457 (UMLS CUI [3,1])
C0332288 (UMLS CUI [3,2])
C4522122 (UMLS CUI [3,3])
Medical contraindication Absent Chemotherapy
Item
3. no contraindication for chemotherapy;
boolean
C1301624 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
C0392920 (UMLS CUI [1,3])
ECOG performance status
Item
4. ecog performance scale 0-2;
boolean
C1520224 (UMLS CUI [1])
Antiangiogenesis therapy Absent
Item
5. no history of anti-angiogenesis therapy;
boolean
C0281318 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
Informed Consent
Item
6. patients are voluntary to participate and sigh the informed contents.
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Antineoplastic Agents
Item
1. concurrent use of other anti-cancer agents;
boolean
C0003392 (UMLS CUI [1])
Hypersensitivity M2ES | Hypersensitivity Biological Factors
Item
2. allergic history to m2es and biological agents;
boolean
C0020517 (UMLS CUI [1,1])
C2985192 (UMLS CUI [1,2])
C0020517 (UMLS CUI [2,1])
C0005515 (UMLS CUI [2,2])
Pregnancy | Breast Feeding
Item
3. pregnant or breast-feeding women;
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Cancer Other
Item
4. with other malignancy;
boolean
C1707251 (UMLS CUI [1])
Cor pulmonale Severe
Item
5. with severe cardiopulmonary disease;
boolean
C0034072 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
Metastatic malignant neoplasm to brain Uncontrolled
Item
6. uncontrolled brain metastasis patients;
boolean
C0220650 (UMLS CUI [1,1])
C0205318 (UMLS CUI [1,2])
Condition Study Subject Participation Status Exclusion
Item
7. other conditions that are regarded for exclusion by the trialists.
boolean
C0348080 (UMLS CUI [1,1])
C2348568 (UMLS CUI [1,2])
C2828389 (UMLS CUI [1,3])
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial